- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03700216
Construction of the Evaluation System of Limb Blood Circulation After Fracture of Limbs in Children
October 17, 2018 updated by: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
This study is aimed to construct a multi-parameter early-warning model based on usage of mannitol, using multi-factor regression and combining with previous clinical experience, literature, expert opinions.
The investigators will evaluate the predictive value of the model for mannitol usage and gypsum cutting open through cohort study verification.
Study Overview
Status
Unknown
Conditions
Detailed Description
The investigator will retrospect the data of operative patients with limb fracture in Pediatric Orthopedics Unit of Shanghai Xinhua Hospital in 2016 to collect the basic information about this kind of patient, including age, gender, kind of fracture, temperature and color of skin, swell, artery pulse, laboratory test indicators, method of fixation, and the usage of mannitol.
Then, combining the professionals' suggestions, the investigator will use multi-factor regression to identify the independent risk factors of blood circulation disorder.
According to the independent risk factors, the early-warning model of blood circulation disorder will be built, and the rating scale as well.
Finally, the critical value of blood circulation disorder after limb fracture will be set by receiver operating characteristic curve.
Study Type
Observational
Enrollment (Anticipated)
201
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200092
- Recruiting
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
-
Contact:
- Ting Zhu, PhD
- Phone Number: +86-18101878907
- Email: zhuting@xinhuamed.com.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 14 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Children with limb fractures diagnosed by X-ray film
Description
Inclusion Criteria:
- Age from 0 to 14 years;
- Children with limb fractures diagnosed by X-ray film;
- The surgical method is open reduction and wire-pin fixation or steel plate internal fixation;
- Children with postoperative plaster fixation;
- Children whose guardian signed informed written consent.
Exclusion Criteria:
- Children with nerve damage which have caused dysfunction such as sensory and motor;
- Children with fracture in other parts or organic diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with Limb Blood circulation disorder
Time Frame: Within 1 year after mannitol treatment
|
Number of participants with circulatory disorders (using mannitol treatment) after limb fracture
|
Within 1 year after mannitol treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of adverse events
Time Frame: Within 1 year after mannitol treatment
|
The adverse events include acute ischemic necrosis, osteofascial compartment syndrome and disability.
|
Within 1 year after mannitol treatment
|
|
Blood oxygen saturation at the end of extremities
Time Frame: Within 1 year after mannitol treatment
|
Oxygen saturation is the fraction of oxygen-saturated hemoglobin relative to total hemoglobin (unsaturated + saturated) in the blood, which can reflect the status of blood circulation.
Blood oxygen saturation can be get by using percutaneous oxygen saturation monitor.
|
Within 1 year after mannitol treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ting Zhu, PhD, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Anticipated)
December 31, 2019
Study Completion (Anticipated)
September 30, 2020
Study Registration Dates
First Submitted
September 26, 2018
First Submitted That Met QC Criteria
October 8, 2018
First Posted (Actual)
October 9, 2018
Study Record Updates
Last Update Posted (Actual)
October 19, 2018
Last Update Submitted That Met QC Criteria
October 17, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XH-18-014
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Circulation Disorder
-
Sahlgrenska University Hospital, SwedenCompletedRenal Function Disorder | Complication of Extracorporeal Circulation | Kidney Circulation DisorderSweden
-
Ceragem Clinical Inc.RecruitingBlood Circulation | Improving Blood CirculationSouth Korea
-
Centre Hospitalier Universitaire de BesanconCompletedCSF Circulation Disorder | Foramen; Monro, Obstruction | MriFrance
-
AHEPA University HospitalCompletedCoagulation Disorder | Extracorporeal Circulation; Complications | Extracorporeal Circulation of Blood; ThrombocytopeniaGreece
-
Oslo University HospitalEuropean CommissionWithdrawnIschemia | Carbon Dioxide | Blood Circulation Disorder | Biosensing TechniquesNorway
-
Oslo University HospitalEuropean CommissionCompletedIschemia | Carbon Dioxide | Blood Circulation Disorder | Biosensing TechniquesNorway
-
Ceragem Clinical Inc.Completed
-
Ceragem Clinical Inc.Completed
-
Oslo University HospitalSensocure ASActive, not recruitingIschemia | Surgery | Blood Circulation Disorder | Biosensing TechniquesNorway
-
Institut National de la Santé Et de la Recherche...CompletedBone Diseases, Metabolic | Blood Circulation DisorderFrance